Eusebio-Ponce E, Anguita E, Paulino-Ramirez R, Candel FJ. HTLV-1 infection: an emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases. Rev Esp Quimioter. 2019;32(6):485–96.

CAS  PubMed  PubMed Central  Google Scholar 

Gessain A, Cassar O. Epidemiological aspects and world distribution of HTLV-1 infection. Front Microbiol. 2012;3:388.

Article  PubMed  PubMed Central  Google Scholar 

Mohanty S, Harhaj EW. Mechanisms of innate immune sensing of HTLV-1 and viral immune evasion. Pathogens. 2023;12(5):735.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Silva MCMD, Pereira RSB, Araujo ACA, Filho EGDS, Dias ADL, Cavalcante KS, Sousa MSD. New perspectives about drug candidates targeting HTLV-1 and related diseases. Pharmaceuticals. 2023;16(11):1546.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bangham CR. Human T cell leukemia virus type 1: persistence and pathogenesis. Annual Rev Immunol. 2018;36(1):43–71. https://doi.org/10.1146/annurev-immunol-042617-053222

Article  CAS  Google Scholar 

Iwanaga M, Watanabe T, Yamaguchi K. Adult T-cell leukemia: a review of epidemiological evidence. Front Microbiol. 2012;3:322.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saito M. Association between HTLV-1 genotypes and risk of HAM/TSP. Front Microbiol. 2019;10:1101.

Article  PubMed  PubMed Central  Google Scholar 

Vallinoto ACR, Cayres-Vallinoto I, Freitas Queiroz MA, Ishak MOG, Ishak R. Influence of immunogenetic biomarkers in the clinical outcome of HTLV-1 infected persons. Viruses. 2019;11(11):974.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao X, O’Brien TR, Welzel TM, Marti D, Qi Y, Goedert JJ, et al. HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection. AIDS. 2010;24(12):1835–40.

Article  CAS  PubMed  Google Scholar 

Muccini C, Guffanti M, Spagnuolo V, Cernuschi M, Galli L, Bigoloni A, et al. Association between low levels of HIV-1 DNA and HLA class I molecules in chronic HIV-1 infection. PLoS ONE. 2022;17(3):e0265348.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dobrijević Z, Gligorijević N, Šunderić M, Penezić A, Miljuš G, Tomić S, Nedić O. The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: a systematic review and meta-analysis. Rev Med Virol. 2023;33(1):e2378.

Article  PubMed  Google Scholar 

Marsh SG, Albert E, Bodmer W, Bontrop R, Dupont B, Erlich H, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens. 2010;75(4):291.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Agresti A. Categorical data analysis. Wiley; 2012.

Google Scholar 

Ciliao Alves DC, Haddad R, Rocha-Júnior MC, de Deus Wagatsuma VM, Martelli-Palomino G, Marques AA, et al. HLA-G 3′-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development. J Gen Virol. 2016;97(10):2742–52.

Article  PubMed  Google Scholar 

Catalan-Soares B, Carneiro-Proietti ABF, Da Fonseca F, Correa-Oliveira R, Peralva-Lima D, Portela R, et al. HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH. Med Microbiol Immunol. 2009;198:1–3.

Article  CAS  PubMed  Google Scholar 

Deschamps R, Béra O, Belrose G, Lezin A, Bellance R, Signate A, et al. Absence of consistent association between human leukocyte antigen-I and-II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population. Int J Infect Dis. 2010;14(11):e986–90.

Article  PubMed  Google Scholar 

Alves DCC, Haddad R, Rocha MC, Wagatsuma VMD, Martelli-Palomino G, Marques AA, et al. HLA-G3’-untranslated region polymorphisms are associated with HTLV-1 infection, proviral load and HTLV-associated myelopathy/tropical spastic paraparesis development. J Gen Virol. 2016;97:2742–52.

Article  CAS  Google Scholar 

Deschamps R, Béra O, Belrose G, Lezin A, Bellance R, Signate A, et al. Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population. Int J Infect Dis. 2010;14(11):e986–90.

Article  PubMed  Google Scholar 

Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T, Jacobson S. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J Exp Med. 1993;177(6):1567–73.

Article  CAS  PubMed  Google Scholar 

Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the <i>tax</i> gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis. 2000;182(5):1343–9.

Article  CAS  PubMed  Google Scholar 

Goedert JJ, Li HC, Gao XJ, Chatterjee N, Sonoda S, Biggar RJ, et al. Risk of human T-lymphotropic virus type I-associated diseases in Jamaica with common HLA types. Int J Cancer. 2007;121(5):1092–7.

Article  CAS  PubMed  Google Scholar 

Group TaBcMS. The third nation-wide study on adult T-cell leukemia/lymphoma (ATL) in Japan: characteristic patterns of hla antigen and HTLV-I infection in ATL patients and their relatives. Int J Cancer. 1988;41(4):505–12.

Article  Google Scholar 

Haddad R, Cilião Alves DC, Rocha-Junior MC, Azevedo R, Pombo-de-Oliveira MS, Takayanagui OM, et al. HLA-G 14-bp insertion/deletion polymorphism is a risk factor for HTLV-1 infection. AIDS Res Hum Retroviruses. 2011;27(3):283–8.

Article  CAS  PubMed  Google Scholar 

Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, et al. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol. 2000;165(12):7278–84.

Article  CAS  PubMed  Google Scholar 

Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci. 1999;96(7):3848–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kozako T, Arima N, Toji S, Masamoto I, Akimoto M, Hamada H, et al. Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients. J Immunol. 2006;177(8):5718–26.

Article  CAS  PubMed  Google Scholar 

Lou H, Li HC, Kuwayama M, Yashiki S, Fujiyoshi T, Suehara M, et al. HLA class I and class II of the Nivkhi, an indigenous population carrying HTLV-I in Sakhalin, Far Eastern Russia. Tissue Antigens. 1998;52(5):444–51.

Article  CAS  PubMed  Google Scholar 

Manns A, Nam J-M, Blattner W, Hanchard B, Morgan OSC, Wilks R, et al. Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia/lymphoma in a Black population. JNCI J Natl Cancer Inst. 1998;90(8):617–22.

Article  CAS  PubMed  Google Scholar 

Nishimura M, Maeda M, Matsuoka M, Mine H, Saji H, Matsui M, et al. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-α, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum Immunol. 2000;61(12):1262–9.

Article  CAS  PubMed  Google Scholar 

Penova M, Kawaguchi S, Yasunaga JI, Kawaguchi T, Sato T, Takahashi M, et al. Genome wide association study of HTLV-1-associated myelopathy/tropical spastic paraparesis in the Japanese population. Proc Natl Acad Sci USA. 2021;118(11):e2004199118.

Article  CAS  PubMed  PubMed Central